PS

Parshva Shashikant Jhaveri

Director Director DIN 02869621
DIN 02869621 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2020
Shareholding value •••• Premium profile

About Parshva Shashikant Jhaveri

Data last updated:

Parshva Shashikant Jhaveri was a Director at Finebiotics Pharma Limited (2020–2024) and Director at Finecure Pharmaceuticals Limited (2021–2024). The companies operate in Pharma.

DIN 02869621
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Finebiotics Pharma Limited U24231GJ2004PLC044581
Director17 Dec 20202004₹26.36 Cr (FY 2025)Active
Finecure Pharmaceuticals Limited U24230GJ2005PLC045724
Director01 Feb 20212005₹202 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Finebiotics Pharma Limited
Finecure Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Parshva Shashikant Jhaveri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parshva Shashikant Jhaveri

Parshva Shashikant Jhaveri was first appointed on 17 Dec 2020 as Director at Finebiotics Pharma Limited. The most recent appointment on record is 01 Feb 2021 at Finecure Pharmaceuticals Limited.

Parshva Shashikant Jhaveri held 2 earlier board appointments: Finebiotics Pharma Limited (Director, 17 Dec 2020 to 01 Nov 2024); Finecure Pharmaceuticals Limited (Director, 01 Feb 2021 to 01 Nov 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available